Literature DB >> 3098977

Effect of measles-virus infection and interferon treatment on invasiveness of Shigella flexneri in HEp2-cell cultures.

G Bukholm, K Modalsli, M Degré.   

Abstract

The influence of measles-virus infection on the invasiveness of Shigella flexneri in HEp2-cell cultures was studied. Bacterial invasiveness was significantly enhanced in cell cultures incubated with virus before bacterial inoculation. This effect was a function of time after introduction of virus to the cell cultures and of the concentration of virus. The increase in bacterial invasiveness was observed before production of infectious virus particles and before a cytopathic effect was evident. A similar enhancement of invasiveness was demonstrated when cell cultures were pretreated with UV-inactivated measles virus. Pretreatment of cells with interferon did not influence invasiveness, although it reduced the effect of measles-virus infection.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3098977     DOI: 10.1099/00222615-22-4-335

Source DB:  PubMed          Journal:  J Med Microbiol        ISSN: 0022-2615            Impact factor:   2.472


  4 in total

1.  Expression of Campylobacter jejuni invasiveness in cell cultures coinfected with other bacteria.

Authors:  G Bukholm; G Kapperud
Journal:  Infect Immun       Date:  1987-11       Impact factor: 3.441

2.  Effect of enteroviruses on adherence to and invasion of HEp-2 cells by Campylobacter isolates.

Authors:  M E Konkel; L A Joens
Journal:  Infect Immun       Date:  1990-04       Impact factor: 3.441

3.  Coxsackie B1 virus-induced changes in cell membrane-associated functions are not responsible for altered sensitivity to bacterial invasiveness.

Authors:  K Modalsli; G Bukholm; S O Mikalsen; M Degré
Journal:  Arch Virol       Date:  1992       Impact factor: 2.574

4.  Hypoxic stress, hepatocytes and CACO-2 viability and susceptibility to Shigella flexneri invasion.

Authors:  Camila Bárbara Cantalupo Lima; Sânia Alves Dos Santos; Dahir Ramos de Andrade Júnior
Journal:  Rev Inst Med Trop Sao Paulo       Date:  2013 Sep-Oct       Impact factor: 1.846

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.